Announcement on Obtaining Drug Registration Certificate for Clopidogrel Aspirin Tablets
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 3 pages · Chinese
Beijing Foyou Pharma Co., Ltd. has announced that it has received a drug registration certificate for Clopidogrel Aspirin Tablets from the National Medical Products Administration. The certificate allows the company to produce this medication, which is indicated for secondary prevention of atherosclerotic thrombotic events. The announcement highlights the potential impact on the company's product line and market competitiveness, while also noting the uncertainties in sales due to regulatory and market factors.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
On 6ix: 6ix.com/news/announcement-on-obtaining-drug-registration-certificate-for-clopidogrel-aspirin-tablets
Announcement on Obtaining Drug Registration Certificate for Clopidogrel Aspirin Tablets
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Beijing Foyou Pharma Co., Ltd. on 6ix
Follow Beijing Foyou Pharma into a list and get an email when it puts out news.
Follow Beijing Foyou Pharma